WikiCitingRetracted

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

Revision as of 00:39, 12 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency; M Victor ; ; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000 ; https://doi.org/0.1515/JPEM.200...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Target ArticleEdit

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency; M Victor ;  ; doi_citing_unknown

RetractionEdit

Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency  ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000

https://doi.org/0.1515/JPEM.2000.13.6.663

Citation pieceEdit

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=A_Summary_of_the_Endocrine_Society_Clinical_Practice_Guidelines_on_Congenital_Adrenal_Hyperplasia_due_to_Steroid_21-Hydroxylase_Deficiency&oldid=9709"